Authors: Schermuly, RT Krupnik, E Tenor, H Schudt, C Weissmann, N Rose, F Grimminger, F Seeger, W Walmrath, D Ghofrani, HA

Citation: Rt. Schermuly et al., Coaerosolization of phosphodiesterase inhibitors markedly enhances the pulmonary vasodilatory response to inhaled iloprost in experimental pulmonary hypertension - Maintenance of lung selectivity, AM J R CRIT, 164(9), 2001, pp. 1694-1700

Authors: Hatzelmann, A Schudt, C

Citation: A. Hatzelmann et C. Schudt, Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro, J PHARM EXP, 297(1), 2001, pp. 267-279

Authors: Hidi, R Timmermans, S Liu, E Schudt, C Dent, G Holgate, ST Djukanovic, R

Citation: R. Hidi et al., Phosphodiesterase and cyclic adenosine monophosphate-dependent inhibition of T-lymphocyte chemotaxis, EUR RESP J, 15(2), 2000, pp. 342-349

Authors: Schermuly, RT Roehl, A Weissmann, N Ghofrani, HA Schudt, C Tenor, H Grimminger, F Seeger, W Walmrath, D

Citation: Rt. Schermuly et al., Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange, J PHARM EXP, 292(2), 2000, pp. 512-520

Authors: Schermuly, RT Ghofrani, HA Enke, B Weissmann, N Grimminger, F Seeger, W Schudt, C Walmrath, D

Citation: Rt. Schermuly et al., Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension, AM J R CRIT, 160(5), 1999, pp. 1500-1506